EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Prevalence of Peri‐Implantitis Around Zirconia Implants: A Systematic Review and Meta‐Analysis of Current Evidence

Vittorio Moraschini, João Baptista de Moraes, Alice Maria de Oliveira Silva, Alexandre Marques Paes da Silva, Rafael Seabra Louro, Eduardo José Veras Lourenço, Victoria L. Souza Costa, Jamil Awad Shibli

Clinical Implant Dentistry and Related Research · 2026-08 · 28 (4)

DOI: 10.1111/cid.70176 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background Zirconia implants (ZIs) have emerged as a metal‐free alternative to titanium implants (TIs) because of their favorable esthetic and biological properties. However, the prevalence of peri‐implantitis associated with ZIs and the potential influence of implant material on peri‐implant disease remain unclear. Objective To estimate the implant‐level prevalence of peri‐implantitis associated with ZIs and to assess whether implant material influences peri‐implantitis prevalence by comparing ZIs and TIs. Methods Electronic searches were conducted in four databases and gray literature sources up to February 2026. Randomized clinical trials (RCTs) and cohort studies evaluating peri‐implantitis associated with ZIs were included. The risk of bias was assessed using the RoB 2 and ROBINS‐I tools. Random‐effects meta‐analyses were performed to estimate the pooled peri‐implantitis prevalence at the implant level. Subgroup analyses according to follow‐up duration and sensitivity analyses were additionally conducted. Results Nineteen studies comprising 687 patients and 995 implants were included. The mean follow‐up reported across studies was approximately 49 months. In studies with follow‐up ≤ 3 years, the pooled prevalence of peri‐implantitis associated with ZIs was 2% (95% CI: 0%–6%; I 2 = 79.3%). Studies with follow‐up > 3 to 5 years demonstrated a pooled prevalence of 2% (95% CI: 0%–8%; I 2 = 38.9%), whereas studies with follow‐up > 5 years showed a pooled prevalence of 8% (95% CI: 0%–23%; I 2 = 82.1%). Comparative analysis of five RCTs demonstrated no statistically significant difference in peri‐implantitis prevalence between ZIs and TIs (RR = 1.66; 95% CI: 0.48–5.71; p = 0.42). Sensitivity analyses did not identify studies with a critical risk of bias as the primary source of heterogeneity. Conclusions Current evidence suggests a low short‐ to mid‐term implant‐level prevalence of peri‐implantitis around ZIs, with higher estimates observed in studies with longer follow‐up. However, the certainty of evidence remains limited because of methodological heterogeneity, variability in diagnostic definitions, inconsistent patient‐level reporting, and the lack of long‐term comparative studies. Limited comparative evidence did not demonstrate a statistically significant difference in peri‐implantitis prevalence between ZIs and TIs.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →